Rhodes DR - Search Results

1

Prostate cancer biomarkers: a current perspective.

Kumar-Sinha C, Rhodes DR, Yu J, Chinnaiyan AM. Kumar-Sinha C, et al. Among authors: rhodes dr. Expert Rev Mol Diagn. 2003 Jul;3(4):459-70. doi: 10.1586/14737159.3.4.459. Expert Rev Mol Diagn. 2003. PMID: 12877385 Review.

2

Statistical issues and methods for meta-analysis of microarray data: a case study in prostate cancer.

Ghosh D, Barette TR, Rhodes D, Chinnaiyan AM. Ghosh D, et al. Funct Integr Genomics. 2003 Dec;3(4):180-8. doi: 10.1007/s10142-003-0087-5. Epub 2003 Jul 22. Funct Integr Genomics. 2003. PMID: 12884057 Free article.

3

Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer.

Rhodes DR, Barrette TR, Rubin MA, Ghosh D, Chinnaiyan AM. Rhodes DR, et al. Cancer Res. 2002 Aug 1;62(15):4427-33. Cancer Res. 2002. PMID: 12154050

4

Dysregulation of the annexin family protein family is associated with prostate cancer progression.

Xin W, Rhodes DR, Ingold C, Chinnaiyan AM, Rubin MA. Xin W, et al. Among authors: rhodes dr. Am J Pathol. 2003 Jan;162(1):255-61. doi: 10.1016/S0002-9440(10)63816-3. Am J Pathol. 2003. PMID: 12507908 Free PMC article.

5

Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer.

Rhodes DR, Sanda MG, Otte AP, Chinnaiyan AM, Rubin MA. Rhodes DR, et al. J Natl Cancer Inst. 2003 May 7;95(9):661-8. doi: 10.1093/jnci/95.9.661. J Natl Cancer Inst. 2003. PMID: 12734317

6

Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression.

Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM. Rhodes DR, et al. Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9309-14. doi: 10.1073/pnas.0401994101. Epub 2004 Jun 7. Proc Natl Acad Sci U S A. 2004. PMID: 15184677 Free PMC article.

7

Bioinformatics strategies for translating genome-wide expression analyses into clinically useful cancer markers.

Rhodes DR, Chinnaiyan AM. Rhodes DR, et al. Ann N Y Acad Sci. 2004 May;1020:32-40. doi: 10.1196/annals.1310.005. Ann N Y Acad Sci. 2004. PMID: 15208181 Free article. Review.

8

Integrative analysis of the cancer transcriptome.

Rhodes DR, Chinnaiyan AM. Rhodes DR, et al. Nat Genet. 2005 Jun;37 Suppl:S31-7. doi: 10.1038/ng1570. Nat Genet. 2005. PMID: 15920528 Review.

9

Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression.

Varambally S, Yu J, Laxman B, Rhodes DR, Mehra R, Tomlins SA, Shah RB, Chandran U, Monzon FA, Becich MJ, Wei JT, Pienta KJ, Ghosh D, Rubin MA, Chinnaiyan AM. Varambally S, et al. Among authors: rhodes dr. Cancer Cell. 2005 Nov;8(5):393-406. doi: 10.1016/j.ccr.2005.10.001. Cancer Cell. 2005. PMID: 16286247 Free article.

10

Integrative molecular concept modeling of prostate cancer progression.

Tomlins SA, Mehra R, Rhodes DR, Cao X, Wang L, Dhanasekaran SM, Kalyana-Sundaram S, Wei JT, Rubin MA, Pienta KJ, Shah RB, Chinnaiyan AM. Tomlins SA, et al. Among authors: rhodes dr. Nat Genet. 2007 Jan;39(1):41-51. doi: 10.1038/ng1935. Epub 2006 Dec 17. Nat Genet. 2007. PMID: 17173048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters